PT  - JOURNAL ARTICLE
AU  - Hupfeld, Kathleen E.
AU  - Zöllner, Helge J.
AU  - Oeltzschner, Georg
AU  - Hyatt, Hayden W.
AU  - Herrmann, Olivia
AU  - Gallegos, Jessica
AU  - Hui, Steve C. N.
AU  - Harris, Ashley D.
AU  - Edden, Richard A. E.
AU  - Tsapkini, Kyrana
TI  - Brain Total Creatine Differs Between Primary Progressive Aphasia (PPA) Subtypes and Correlates with Disease Severity
AID  - 10.1101/2022.05.20.22275384
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.05.20.22275384
4099  - http://medrxiv.org/content/early/2022/10/05/2022.05.20.22275384.short
4100  - http://medrxiv.org/content/early/2022/10/05/2022.05.20.22275384.full
AB  - Primary progressive aphasia (PPA) is comprised of three subtypes: logopenic (lvPPA), non-fluent (nfvPPA), and semantic (svPPA). We used magnetic resonance spectroscopy (MRS) to measure tissue-corrected metabolite levels in the left inferior frontal gyrus (IFG) and right sensorimotor cortex (SMC) from 61 PPA patients. We aimed to: 1) characterize subtype differences in metabolites; and 2) test for metabolite associations with symptom severity. tCr differed by subtype across the left IFG and right SMC. tCr levels were lowest in lvPPA and highest in svPPA. tCr levels predicted lvPPA versus svPPA diagnosis. Higher IFG tCr and lower Glx correlated with greater disease severity. As tCr is involved in brain energy metabolism, svPPA pathology might involve changes in specific cellular energy processes. Perturbations to cellular energy homeostasis in language areas may contribute to symptoms. Reduced cortical excitatory capacity (i.e., lower Glx) in language regions may also contribute to symptoms. Thus, tCr may be useful for differentiating between PPA subtypes, and both tCr and Glx might have utility in understanding PPA mechanisms and tracking progression.HighlightsNo prior work has examined differences in brain metabolite levels for PPA subtypes.Total creatine (tCr) levels were lowest in lvPPA and highest in svPPA.tCr levels differentiated lvPPA from svPPA diagnosis.Higher tCr and lower Glx in the left IFG correlated with greater disease severity.Changes in cellular energy and excitatory processes may relate to PPA pathology.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by grants from the National Institute on Aging (K00 AG068440-03 to KH, R00 AG062230 to GO, and R01 DC014475-05 and R01 AG068881-02 to KT) and grants from the National Institute of Biomedical Imaging and Bioengineering (R01 EB016089 to RE, and P41 EB031771).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Johns Hopkins University Institutional Review Board gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe raw data supporting the conclusions of this manuscript will be made available by the authors without undue reservation.